ITT / I. Sodium Nitroprusside Summary Review / Abbott Laboratories / /
Country
United States / / /
Event
FDA Phase / /
Facility
Stanford University / National Institute of Diabetes / Eunice Kennedy Shriver National Institute of Child Health / Duke University / P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes / Two Democracy Plaza / / /
IndustryTerm
reasonable algorithm / large site / grant applications / healthcare / insight on device / biofilm prevention technologies / implanted and indwelling devices / /
National Institute of Health / National Institute of Diabetes / office of Surveillance and Epidemiology / U.S. Government / Human Development / Division of Cardiovascular / office of Federal Advisory Committee Policy / DEPARTMENT OF HOMELAND SECURITY Agency Information Collection Activities / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Duke University / DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive / office of Scientific Investigations / Division of Cardiovascular and Renal Products / Division of Dockets Management / Stanford University / Summary Report and Requested Labeling Changes AGENCY / FDA / Eunice Kennedy Shriver National Institute of Child Health / Eunice Kennedy Shriver National Institute of Child Health and Human Development / Department of Homeland Security / Center for Drug Evaluation and Research / Requested Labeling Changes AGENCY / FR Doc / /
Person
David Rosen / Najma Begum / Leslie Kux / David Clary / Silver Spring / / /
Position
Investigator / Law Enforcement Officer / Assistant Commissioner for Policy / Governor / Program Analyst / Scientific Review Officer / Major Ongoing Clinical Research / /